Interestingly, TGF-β1 and 3 mRNA levels correlated with the degree of weakness of the biopsied muscle, suggesting that these targets may reflect the severity of disease involvement in human ALS. This evidence concerns the gene TGFB1 and amyotrophic lateral sclerosis.